Versartis Inc. (VSAR)

5.96
0.01 0.25
NASDAQ : Health Technology
Prev Close 5.97
Open 5.93
Day Low/High 5.93 / 6.00
52 Wk Low/High 3.07 / 13.80
Volume 1.95K
Avg Volume 207.40K
Exchange NASDAQ
Shares Outstanding 36.24M
Market Cap 43.13M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Versartis Initiates Global Phase 3 Study Of VRS-317 In Children With Growth Hormone Deficiency

Versartis Initiates Global Phase 3 Study Of VRS-317 In Children With Growth Hormone Deficiency

The VELOCITY Study Begins for Long-Acting Recombinant Human Growth Hormone in GHD Pediatric Patients

Versartis To Hold Conference Call To Discuss VRS-317 Clinical Update From Ongoing Extension Study

Versartis To Hold Conference Call To Discuss VRS-317 Clinical Update From Ongoing Extension Study

Conference Call and Webcast Scheduled at 8:30 a.m. ET on January 5, 2015

Versartis Reports Third Quarter 2014 Financial Results

Versartis Reports Third Quarter 2014 Financial Results

Conference Call and Webcast Scheduled for 4:30 p.m. ET on November 6, 2014

Keith Lui Joins Versartis To Lead Global Marketing Efforts

Keith Lui Joins Versartis To Lead Global Marketing Efforts

Versartis Strengthens Leadership Team to Prepare for Commercialization of VRS-317

Versartis Schedules Conference Call To Discuss Plans For Phase 3 Trial For VRS-317 In Pediatric Growth Hormone Deficiency Patients

Versartis Schedules Conference Call To Discuss Plans For Phase 3 Trial For VRS-317 In Pediatric Growth Hormone Deficiency Patients

Conference Call Will Include Third Quarter 2014 Financial Results and Business Update

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Versartis (VSAR) Surges on First Trading Day

Versartis (VSAR) Surges on First Trading Day

Biopharmaceutical company Versartis (VSAR) closed up 47.62% to $31 on Friday, its first day of trading after the company's initial public offering. The stock surged more than 50% to a high of $36.30 for the day. Nearly 6 million shares changed hands on Friday. Versartis upsized its IPO and earned $126 million by selling 6 million shares at $21 a share, the high end of its range of $19 to $21 a share. The company had previously expected to sell 4.6 million shares at $16 to $19 a share.